BioTricity Inc. Files Definitive Proxy Statement

TL;DR

BioTricity proxy filed - vote on directors & auditors coming up.

AI Summary

BioTricity Inc. filed its definitive proxy statement on August 5, 2024, for its annual meeting of stockholders. The filing outlines proposals for the election of directors, ratification of the appointment of its independent registered public accounting firm, and other business as may properly come before the meeting. The company is seeking shareholder approval for key corporate governance matters.

Why It Matters

This filing is crucial for shareholders as it details the proposals they will vote on at the annual meeting, impacting the company's leadership and governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing detailing upcoming shareholder votes, not indicating new financial risks.

Key Players & Entities

• BIOTRICITY INC. (company) — Registrant
• 0001493152-24-030135.txt (document) — Filing document identifier
• 20240805 (date) — Filing date
• METASOLUTIONS, INC. (company) — Former company name

FAQ

Key Financial Figures

• $6,600,000 — 3. To approve the issuance of up to $6,600,000 of the Company’s common stock upo
• $10,000 — basis, using a defined Stated Value of $10,000 per share and a Conversion Price, which
• $3 — on Price, which is initially a price of $3.50, subject to further adjustments. Q

Filing Documents

• formdef14a.htm (DEF 14A) — 522KB
• 0001493152-24-030135.txt ( ) — 523KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 22 Summary Compensation Table 22 Narrative Disclosure to Summary Compensation Table 22 Employment Agreements 22 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END 24 DIRECTOR COMPENSATION 24 TRANSACTION WITH RELATED PERSONS 25 STOCK OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT OF BIOTRICITY INC. 25 HOUSEHOLDING OF MATERIALS 26 STOCKHOLDER PROPOSALS FOR THE 2023 ANNUAL MEETING 26 OTHER MATTERS 27 ANNUAL REPORT 27 QUESTIONS AND ANSWERS The following are some questions that you, as a stockholder of the Company, may have about the Meeting, the proposals being considered at the Meeting, as applicable, and brief answers to those questions. These questions and answers may not address all questions that may be important to you as a stockholder of the Company. We encourage you to read carefully the more detailed information contained elsewhere in this proxy statement. Q: Why am I receiving this proxy statement? A: These proxy materials describe the proposals on which the Company would like you to vote and also give you information on these proposals so that you can make an informed decision. We are furnishing our proxy materials to all stockholders of record entitled to vote at the Meeting. As a stockholder, you are invited to attend the Meeting and are entitled and requested to vote on the proposals described in this proxy statement. Q: When and where is the Meeting? A: The Meeting will take place on August 15, 2024, starting at 10:00 a.m., Pacific Time, at 203 Redwood Shores Parkway, Suite 600, Redwood Q: Who is entitled to vote at the Meeting? A: Only stockholders who our records show owned shares of our common stock and Special Voting Preferred Stock as of the close of business on July 15, 2024, which is the record date for the Meeting (the “Record Date”), may vote at the Meeting. The holders of our common stock have one (1) vote for each share of the Com

View Full Filing

View this DEF 14A filing on SEC EDGAR